Covista Common Shares (CVSA) closed at $110.32 on November 6, 2026, down 2.3% from the previous close, on volume of 683,245 shares (30-day average 368,025).
Data as of November 6, 2026.
6-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 27, 2026 | Call with Delta Hedge | 20-Nov-26 140 C +33,184 Stock | 897 |
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 6, 2026. See the 10 largest for 30, 60 and 90 days
Covista Raises FY2027 Guidance as Enrollment Hits 104,713 in a 13-Quarter Growth Streak
Market Chameleon (Fri, 30-Oct 7:34 AM ET)
Business Wire (Thu, 29-Oct 4:05 PM ET)
Covista Recognized by TIME and Newsweek for Growth, Workplace Culture and Sustainability
Business Wire (Tue, 27-Oct 9:00 AM ET)
Business Wire (Thu, 22-Oct 5:30 PM ET)
Business Wire (Tue, 13-Oct 6:00 AM ET)
The DAISY Foundation Names Walden University an Extraordinary Educational Partner
Business Wire (Thu, 1-Oct 8:00 AM ET)
Covista Announces First Quarter Fiscal Year 2027 Conference Call
Business Wire (Tue, 29-Sep 8:08 AM ET)
The Healthcare Workforce Gap Is Set to Nearly Double by 2040
Business Wire (Mon, 28-Sep 5:00 AM ET)
Business Wire (Tue, 15-Sep 10:19 AM ET)
Covista Inc is America's healthcare educator across five accredited institutions: Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. It delivers education to its students at multiple campuses and online. Its segments are Chamberlain, Walden, and Medical and Veterinary. Walden generates maximum revenue and includes the operations of Walden, which offers degree and certificate programs, including those in nursing, education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. The Company generates maximum revenue from Domestic operations.
Covista Common Shares trades on the NYSE stock market under the symbol CVSA.
As of November 6, 2026, CVSA stock price declined to $110.32 with 683,245 million shares trading.
CVSA has a beta of 0.62, meaning it tends to be less sensitive to market movements. CVSA has a correlation of 0.03 to the broad based SPY ETF.
CVSA has a market cap of $3.67 billion. This is considered a Mid Cap stock.
Last quarter Covista Common Shares reported $512 million in Revenue and $2.19 earnings per share. This beat revenue expectation by $21 million and exceeded earnings estimates by $.35.
The top ETF exchange traded funds that CVSA belongs to (by Net Assets): IJR, VTI, IWM, VB, DFAT.
CVSA support price is $109.80 and resistance is $116.12 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CVSA shares will trade within this expected range on the day.
